Eicosanoids in atherosclerosis.

[1]  J. Dyerberg.  Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. , 2009, Nutrition reviews.

[2]  K. Rák,et al.  Congenital Deficiency Of Cyclo-Oxygenase In A Woman With Generalized Arteriosclerosis , 2009, Thrombosis and Haemostasis.

[3]  N Kromann,et al.  Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. , 2009, Acta medica Scandinavica.

[4]  P. Angelberger,et al.  Effect of prostaglandin E1 on low density lipoprotein apo-B-receptor binding in human, rat and swine liver in vitro. , 1991, Prostaglandins.

[5]  H. Sinzinger,et al.  Platelet lipoxygenase defect (wien‐penzing defect) in two patients with myocardial infarction , 1991, American journal of hematology.

[6]  H. Sinzinger,et al.  Defects in the prostaglandin-system--heredity, prevalence and vascular risk analysis. , 1990, Prostaglandins, leukotrienes, and essential fatty acids.

[7]  J. Vane,et al.  Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease , 1990, The Lancet.

[8]  H. Sinzinger,et al.  Decrease of the prostaglandin I2 binding capacity in thyroids from patients with Graves' disease. , 1989, Prostaglandins, leukotrienes, and essential fatty acids.

[9]  W. Schütz,et al.  Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level. , 1988, Prostaglandins.

[10]  P. Weber,et al.  Cardiovascular effects of N-3 fatty acids. , 1988, Journal of nutritional science and vitaminology.

[11]  A. Dutta-Roy,et al.  Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. , 1987, The Journal of biological chemistry.

[12]  H. Sinzinger,et al.  Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular disease. , 1987, Prostaglandins, leukotrienes, and medicine.

[13]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[14]  D. Horrobin.  Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? , 1987, Medical hypotheses.

[15]  C. Taube,et al.  Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. , 1986, Atherosclerosis.

[16]  J. Dyerberg,et al.  The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos. , 1986, Prostaglandins.

[17]  G. FitzGerald,et al.  In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. , 1986, The New England journal of medicine.

[18]  C. Forbes,et al.  Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura. , 1986, Archives of disease in childhood.

[19]  A. Todisco,et al.  Partial isolation and function of the prostacyclin regulating plasma factor. , 1985, Clinical science.

[20]  C. von Schacky,et al.  Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985, The Journal of clinical investigation.

[21]  D. Sullivan,et al.  Triglyceride‐Lowering Effect of Marine Polyunsaturates in Patients with Hypertriglyceridemia , 1985, Arteriosclerosis.

[22]  M. Wirth,et al.  Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. , 1985, Atherosclerosis.

[23]  W. Harris,et al.  Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia , 1985 .

[24]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[25]  H. Sinzinger,et al.  REBOUND PLATELET ACTIVATION DURING CONTINUOUS EPOPROSTENOL INFUSION , 1984, The Lancet.

[26]  A. Todisco,et al.  PROLONGING PROSTACYCLIN PRODUCTION BY NAFAZATROM OR DIPYRIDAMOLE , 1984, The Lancet.

[27]  W. Harris,et al.  Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. , 1984, Arteriosclerosis.

[28]  A. Turnbull,et al.  Arachidonic acid metabolism by the non-pregnant human uterus. , 1984, Prostaglandins, leukotrienes, and medicine.

[29]  H. Sinzinger,et al.  Prostacyclin-synthesis-stimulating plasma factor in patients with different stages of hepatic coma. , 1984, Prostaglandins, leukotrienes, and medicine.

[30]  J. Vane,et al.  The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes. , 1984, Prostaglandins.

[31]  D. N. Landon,et al.  Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. , 1984, Prostaglandins.

[32]  P. Weber,et al.  Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3) , 1983 .

[33]  D. Dewitt,et al.  Purification of prostacyclin synthase from bovine aorta by immunoaffinity chromatography. Evidence that the enzyme is a hemoprotein. , 1983, The Journal of biological chemistry.

[34]  G. Remuzzi,et al.  Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect. , 1983, The Journal of clinical investigation.

[35]  B. Vargaftig,et al.  Familial and constitutional bleeding disorder due to platelet cyclo‐oxygenase deficiency , 1983, American journal of hematology.

[36]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.

[37]  K. Svanborg,et al.  Quantification of prostaglandins in human seminal fluid. , 1982, Prostaglandins.

[38]  L. Aiken.  Book ReviewSocial Contexts of Health, Illness, and Patient Care The Social Context of Medical Research , 1982 .

[39]  W. Harris,et al.  Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. , 1982, Arteriosclerosis.

[40]  A. Schafer.  Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. , 1982, The New England journal of medicine.

[41]  J. Vermylen,et al.  Familial Bleeding Tendency with Partial Platelet Thromboxane Synthetase Deficiency: Reorientation of Cyclic Endoperoxide Metabolism , 1981, British journal of haematology.

[42]  C. Cerletti,et al.  INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATION , 1981, The Lancet.

[43]  F. ten Hoor,et al.  Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. , 1981, Prostaglandins.

[44]  M. Mitchell.  Prostaglandins during pregnancy and the perinatal period. , 1981, Journal of reproduction and fertility.

[45]  G. Weissmann,et al.  Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenazo III in liposomes. , 1981, The Journal of biological chemistry.

[46]  H M Sinclair,et al.  The composition of the Eskimo food in north western Greenland. , 1980, The American journal of clinical nutrition.

[47]  F. Hirata,et al.  Phospholipid methylation and biological signal transmission. , 1980, Science.

[48]  J. Dyerberg,et al.  The bleeding tendency in Greenland Eskimos. , 1980, Danish medical bulletin.

[49]  J. Vermylen,et al.  A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells. , 1980, Thrombosis research.

[50]  M. Lagarde,et al.  Fatty acids bound to serumalbumin decrease the half-life of thromboxane A2. , 1980, Prostaglandins.

[51]  E. Änggård,et al.  Prostaglandin Profiles in Tissue and Blood Vessels from Human Brain , 1980, Journal of neurochemistry.

[52]  P. Mannucci,et al.  CONGENITAL DEFICIENCY OF THROMBOXANE AND PROSTACYCLIN , 1980, The Lancet.

[53]  Martin Rodbell,et al.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction , 1980, Nature.

[54]  S. Hammarström.  Enzymatic synthesis of 15-hydroperoxythromboxane A2 and 12-hydroperoxy-5,8,10-heptadecatrienoic acid. , 1980, The Journal of biological chemistry.

[55]  P. Imbach,et al.  SEVERE BLEEDING ASSOCIATED WITH DEFECTIVE THROMBOXANE SYNTHETASE , 1980, The Lancet.

[56]  J. Hirsh,et al.  Shortening of the bleeding time in thrombocytopenic rabbits after exposure of jugular vein to high aspirin concentration. , 1979, Prostaglandins and medicine.

[57]  M. Okuma,et al.  Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. , 1979, Blood.

[58]  C. Seachord,et al.  A dominant role of thromboxane formation in secondary aggregation of platelets , 1979, Nature.

[59]  M. Mitchell,et al.  PROSTACYCLIN AND THROMBOXANE METABOLITES IN DIABETES , 1979, The Lancet.

[60]  S. Yamamoto,et al.  Purification and properties of prostaglandin D synthetase from rat brain. , 1979, The Journal of biological chemistry.

[61]  M. Caton,et al.  Prostaglandins and thromboxanes. , 1979, Progress in medicinal chemistry.

[62]  A. Szczeklik,et al.  SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN , 1979, The Lancet.

[63]  A. Schafer,et al.  Identification of platelet receptors for prostaglandin I2 and D2. , 1979, The Journal of biological chemistry.

[64]  J. Vermylen,et al.  STIMULATION OF PROSTACYCLIN RELEASE FROM VESSEL WALL BY BAY g 6575, AN ANTITHROMBOTIC COMPOUND , 1979, The Lancet.

[65]  N. Russell,et al.  Thrombocytopathy in Preleukaemia: Association with a Defect of Thromboxane A2 Activity , 1979, British journal of haematology.

[66]  J. Ferrendelli,et al.  Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Kelly.  Prostaglandins in Semen: Their Occurrence and Possible Physiological Significance , 1978 .

[68]  A. Dembińska-kieć,et al.  Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. , 1978, Atherosclerosis.

[69]  G. Remuzzi,et al.  HÆMOLYTIC-URÆMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY? , 1978, The Lancet.

[70]  G. Remuzzi,et al.  Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis. , 1978, Thrombosis research.

[71]  J. Oates,et al.  Metabolism of thromboxane B2 in the monkey. , 1978, The Journal of biological chemistry.

[72]  A. Sedar,et al.  Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. , 1978, Blood.

[73]  J. Vane,et al.  EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS? , 1978, The Lancet.

[74]  R. Skidgel,et al.  PGI2 production by rat blood vessels: diminished prostacyclin formation in veins compared to arteries. , 1978, Prostaglandins.

[75]  D. Aharony,et al.  Biosynthesis of thromboxane B2 and 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Evidence for a common enzymatic pathway. , 1978, European journal of biochemistry.

[76]  J. Byrnes,et al.  Treatments for thrombotic thrombocytopenic purpura: plasma, vincristine, hemodialysis and exchange transfusions. , 1978, The New England journal of medicine.

[77]  J. Pearson,et al.  Localisation and stimulation of prostacyclin production in vascular cells , 1978, Nature.

[78]  E. Goetzl,et al.  Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). , 1978, Journal of immunology.

[79]  M. Lagarde,et al.  Impairment of Platelet Thromboxane A2 Generation and of the Platelet Release Reaction in Two Patients with Congenital Deficiency of Platelet Cyclo‐oxygenase , 1978, British journal of haematology.

[80]  U. Diczfalusy,et al.  Conversion of prostaglandin endoperoxides to C17‐hydroxy acids catalyzed by human platelet thromboxane synthase , 1977, FEBS letters.

[81]  M. Okuma,et al.  Platelet lipoxygenase deficiency. , 1977, The New England journal of medicine.

[82]  A. Bennett,et al.  ESTIMATION AND CHARACTERIZATION OF PROSTAGLANDINS IN THE HUMAN GASTROINTESTINAL TRACT , 1977, British journal of pharmacology.

[83]  E. Granström,et al.  Albumin stabilizes thromboxane A2 , 1977, FEBS letters.

[84]  M. Hamberg,et al.  Thromboxane A2: effects on airway and vascular smooth muscle. , 1977, Prostaglandins.

[85]  J. Vane,et al.  Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. , 1977, Thrombosis research.

[86]  S. Yamamoto,et al.  Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. , 1977, The Journal of biological chemistry.

[87]  G. Milo,et al.  Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. , 1977, Science.

[88]  H. Weiss,et al.  POSSIBLE CONGENITAL DEFECT IN PLATELET THROMBOXANE SYNTHETASE , 1977, The Lancet.

[89]  S. Yamamoto,et al.  Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. , 1977, The Journal of biological chemistry.

[90]  J. Oates,et al.  Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. , 1977, Prostaglandins.

[91]  J. Wharton,et al.  Defective Platelet Lipid Peroxidation in Myeloproliferative Disorders: A Possible Defect of Prostaglandin Synthesis , 1977, British journal of haematology.

[92]  E. Christ-Hazelhof,et al.  Conversions of prostaglandin endoperoxides by glutathione-S-transferases and serum albumins. , 1976, Biochimica et biophysica acta.

[93]  R. A. Johnson,et al.  The chemical structure of prostaglandin X (prostacyclin). , 1976, Prostaglandins.

[94]  M. Hamberg,et al.  On the formation and effects of thromboxane A2 in human platelets. , 1976, Acta physiologica Scandinavica.

[95]  J. Smith,et al.  Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma. , 1976, The Journal of clinical investigation.

[96]  B. Samuelsson,et al.  Radioimmunoassay for Thromboxane B2 , 1976 .

[97]  J. Smith,et al.  Malondialdehyde formation as an indicator of prostaglandin production by human platelets. , 1976, The Journal of laboratory and clinical medicine.

[98]  J. Mustard,et al.  Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. , 1976, Science.

[99]  S. Yamamoto,et al.  Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. , 1976, The Journal of biological chemistry.

[100]  F. L. Gueriguian.  Prostaglandin-macromolecule interactions. I. Noncovalent binding of prostaglandins A1, E1, F2alpha, and E2 by human and bovine serum albumins. , 1976, The Journal of pharmacology and experimental therapeutics.

[101]  G. J. Blackwell,et al.  The importance of phospholipase-A2 in prostaglandin biosynthesis. , 1976, Biochemical pharmacology.

[102]  M. Hamberg,et al.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[103]  M. Hamberg,et al.  Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[104]  M. Hamberg,et al.  Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Hamberg,et al.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[106]  K.,et al.  Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig. , 1974, The Journal of clinical investigation.

[107]  R. Ross,et al.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[108]  J. Smith,et al.  Formation of prostaglandins during the aggregation of human blood platelets. , 1973, The Journal of clinical investigation.

[109]  L. Carlson,et al.  Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease. , 1973, Lancet.

[110]  J. Dyerberg,et al.  Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. , 1971, Lancet.

[111]  J. Smith,et al.  Formation and release of prostaglandins by platelets in response to thrombin. , 1970, British journal of pharmacology.

[112]  J. Peterson,et al.  Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. , 1970, The Journal of laboratory and clinical medicine.

[113]  J. Vane,et al.  Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs , 1969, Nature.

[114]  H. Vonkeman.  [The biosynthesis of prostaglandins]. , 1964, Chemisch weekblad.

[115]  B. Samuelsson,et al.  THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32. , 1964, Biochimica et biophysica acta.

[116]  B. Samuelsson.  ISOLATION AND IDENTIFICATION OF PROSTAGLANDINS FROM HUMAN SEMINAL PLASMA. 18. PROSTAGLANDINS AND RELATED FACTORS. , 1963, The Journal of biological chemistry.

[117]  E. Sutherland,et al.  THE PROPERTIES OF AN ADENINE RIBONUCLEOTIDE PRODUCED WITH CELLULAR PARTICLES, ATP, Mg++, AND EPINEPHRINE OR GLUCAGON , 1957 .

[118]  C. C. Lieb,et al.  Biochemical Studies of Human Semen.∗ II. The Action of Semen on the Human Uterus. , 1930 .

[119]  G. Burr,et al.  Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. , 1929, Nutrition reviews.

[120]  H. Sinzinger,et al.  Extremely prolonged half-life of prostacyclin in plasma causative for bleeding in an uremic patient? , 1991, Nephron.

[121]  D. Dewitt,et al.  Molecular characterization of the prostacyclin synthase. , 1987, Advances in prostaglandin, thromboxane, and leukotriene research.

[122]  D. H. Greene,et al.  Lipid metabolism in fish. , 1987, Progress in lipid research.

[123]  K. Seibert,et al.  Isomeric prostaglandin F2 compounds: a new family of eicosanoids produced in vivo in humans. , 1987, Advances in prostaglandin, thromboxane, and leukotriene research.

[124]  B. Jankovic,et al.  Investigation of selective [3H]iloprost binding sites on human platelet membranes. , 1987, Progress in clinical and biological research.

[125]  W. Lands.  Fish and human health. , 1986 .

[126]  M. Gerritsen.  PGD2 formation in the vasculature: characteristics of rat tail vein prostaglandin endoperoxide-D isomerase. , 1983, Prostaglandins.

[127]  F. Assche,et al.  Prostacyclin (pgi2) production by aortic rings and mesometrial triangles in pregnant rats, fed an anti-vitamin-e stress diet , 1983 .

[128]  A. Todisco,et al.  The prostacyclin stimulating plasma factor (pspf) protects endothelial-cells from exhaustion , 1983 .

[129]  U. Diczfalusy,et al.  Biosynthesis of thromboxanes. , 1980, Advances in prostaglandin and thromboxane research.

[130]  E. Corey,et al.  Recent studies on the chemical synthesis of eicosanoids. , 1980, Advances in prostaglandin and thromboxane research.

[131]  W. Lands.  The biosynthesis and metabolism of prostaglandins. , 1979, Annual review of physiology.

[132]  R. Ryhage,et al.  The structure of prostaglandin E F1 and F2. , 1962 .

[133]  S. Åsbrink,et al.  The Isolation of Prostaglandin. , 1957 .